VARIAN MEDICAL SYSTEMS, INC. (NYSE:VAR) Files An 8-K Regulation FD Disclosure

VARIAN MEDICAL SYSTEMS, INC. (NYSE:VAR) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.

Management of Varian Medical Systems, Inc. (the “Company”) will use the information in the presentation slides attached hereto as Exhibit 99.1 in the previously announced conference call with institutional investors and analysts on January 11, 2018 to discuss its transition to new Accounting Standard Codification 606 (“606”). The attached presentation and related webcast will be accessible through the “Investors” section of Company’s website at

The information included in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 that is provided to this Item 7.01, is being furnished and shall not be deemed to be filed for purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended.

Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following exhibit is being furnished, and is not deemed to be filed:

EX-99.1 2 tv483154_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1   New revenue accounting standard (ASC 606) and FY18 guidance January 11,…
To view the full exhibit click here


Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions. The Company is an also a supplier of X-ray imaging components. It operates through two segments: Oncology Systems and Imaging Components. The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy and treatments, and brachytherapy, as well as informatics software for information management, clinical knowledge exchange, patient care management, practice management and decision-making support for cancer clinics, radiotherapy centers and medical oncology practices. The Imaging Components segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer-aided diagnostics and industrial applications.

An ad to help with our costs